Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102721453 | 10272145 | 3 | F | 20140618 | 20140826 | 20140702 | 20151231 | EXP | US-ROCHE-1425665 | ROCHE | 33.17 | YR | F | Y | 71.28000 | KG | 20151231 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102721453 | 10272145 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 4 MG/KG | 121214 | 325 | MG | SOLUTION FOR INFUSION | |||||||
| 102721453 | 10272145 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 121214 | 8 | MG/KG | SOLUTION FOR INFUSION | ||||||||
| 102721453 | 10272145 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 2 CAPS AT BEDTIME FOR LAST 6 MONTHS | 0 | CAPSULE | QD | ||||||||
| 102721453 | 10272145 | 4 | C | DICLOFENAC | DICLOFENAC | 1 | Unknown | LAST 6 MONTHS | 0 | QD | |||||||||
| 102721453 | 10272145 | 5 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | EXTENDED RELEASE; EVERY NIGHT FOR LAST 3 YEARS | 0 | QD | |||||||||
| 102721453 | 10272145 | 6 | C | CELEXA (UNITED STATES) | 2 | Unknown | DAY FOR LAST 3 YEARS | 0 | QD | ||||||||||
| 102721453 | 10272145 | 7 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | 40 | MG | BID | ||||||||
| 102721453 | 10272145 | 8 | C | OXYCODONE | OXYCODONE | 1 | Unknown | EVERY DAY, 4 TABS DAILY | 0 | 15 | MG | TABLET | QID | ||||||
| 102721453 | 10272145 | 9 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 1/2 TAB EVERY AM AND 1 TAB PRN DAILY | 0 | QD | |||||||||
| 102721453 | 10272145 | 10 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Unknown | FOR LAST YEAR. | 0 | 10 | MG | BID | |||||||
| 102721453 | 10272145 | 11 | C | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | INCREASED A MONTH AGO TO 10 MG EVERY MORNING AND 10 MG EVERY EVENING | 0 | QD | |||||||||
| 102721453 | 10272145 | 12 | C | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 0 | BID | ||||||||||
| 102721453 | 10272145 | 13 | C | AMOXICILLIN. | AMOXICILLIN | 1 | 0 | ||||||||||||
| 102721453 | 10272145 | 14 | C | METHOTREXATE | METHOTREXATE | 1 | Subcutaneous | SC FOR LAST 3 YEARS BUT PO FOR 5 YEARS | 0 | .8 | ML | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102721453 | 10272145 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102721453 | 10272145 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102721453 | 10272145 | Dehydration | |
| 102721453 | 10272145 | Diarrhoea | |
| 102721453 | 10272145 | Ear infection | |
| 102721453 | 10272145 | Injection site bruising | |
| 102721453 | 10272145 | Nausea | |
| 102721453 | 10272145 | Rash erythematous | |
| 102721453 | 10272145 | Thrombophlebitis superficial | |
| 102721453 | 10272145 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |